 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
8 News |  |
- | LY3053102 / Eli Lilly
Enrollment change, Trial termination: A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes (clinicaltrials.gov) - Feb 26, 2015
P1/2, N=60, Terminated, Sponsor: Eli Lilly and Company
N=375 --> 60 | Active, not recruiting --> Terminated; Lack of Efficacy
- || LY3053102 / Eli Lilly
Trial primary completion date: A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes (clinicaltrials.gov) - Feb 3, 2015
P1/2, N=375, Active, not recruiting, Sponsor: Eli Lilly and Company
N=375 --> 60 | Active, not recruiting --> Terminated; Lack of Efficacy Trial primary completion date: Sep 2015 --> Feb 2015
- ||| LY3053102 / Eli Lilly
Enrollment closed: A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes (clinicaltrials.gov) - Dec 17, 2014
P1/2, N=375, Active, not recruiting, Sponsor: Eli Lilly and Company
Trial primary completion date: Sep 2015 --> Feb 2015 Recruiting --> Active, not recruiting
- |||| LY3053102 / Eli Lilly
Enrollment open: A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes (clinicaltrials.gov) - Jan 7, 2014
P1/2, N=375, Recruiting, Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| LY3053102 / Eli Lilly
New P1/2 trial: A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes (clinicaltrials.gov) - Dec 23, 2013
P1/2, N=375, Recruiting, Sponsor: Eli Lilly and Company
- ||| LY3053102 / Eli Lilly
Trial completion: A Study of LY3053102 in Healthy Participants (clinicaltrials.gov) - Jul 11, 2013
P1, N=53, Completed, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| LY3053102 / Eli Lilly
New P1 trial: A Study of LY3053102 in Healthy Participants (clinicaltrials.gov) - Nov 27, 2012
P1, N=53, Completed, Sponsor: Eli Lilly and Company